Introduction Most cervical cancer patients in LMICs tend to present at an advanced stage with associated health and psychological difficulties. This can affect their quality of life (QOL). There is limited published data about the QOL of women with cervical cancer in LMICs. AIM: To evaluate the QOL among women newly diagnosed with cervical cancer.

Methods This was a cross-sectional study of the QOL in women recently diagnosed Cervical Cancer (treatment naïve) using a validated tool, the Quality of Life Questionnaire domains (EORTC QLQ30) administered by trained assistants. The study was conducted from May 2022 to April 2023 in 6 tertiary health facilities, selected by multistage stratified sampling technique in 120 eligible consenting participants. The QOL score was graded into 5 categories: (≤15 - very good,16–30– Good, 31–60– poor, 61–75– very poor, and ≥76– worst). All data were exported into SPSS version 26 for analysis. Ethical approval was obtained.

Results The commonest age range (23.33%) was 44–49 years, 64.17% were married and 59.17% had monthly income less than $33.2. Stage 4 (39.83%) and 3 (33.90%) disease were commonest. Most (71.67%) had poor quality of life while 20% had good quality of life. Half of the participants rated their perception of quality of life as poor and very poor (36.67% & 13.33% respectively). Depression(53.3%), difficulty controlling bowel (30%), and painful sex (20.8%) were common complaints.

Conclusion/Implications Majority of women newly diagnosed with cervical cancer in Nigeria had poor QOL. This needs to be a consideration when planning their treatment